Genomma Lab InternacionalB de CV (Genomma Lab InternacionalB de CV) Change In Payables And Accrued Expense : $0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Genomma Lab InternacionalB de CV Change In Payables And Accrued Expense?

Genomma Lab InternacionalB de CV's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was $0.0 Mil. It means Genomma Lab InternacionalB de CV's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Mar. 2024 .

Genomma Lab InternacionalB de CV's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $0.0 Mil. It means Genomma Lab InternacionalB de CV's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Genomma Lab InternacionalB de CV Change In Payables And Accrued Expense Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV Change In Payables And Accrued Expense Chart

Genomma Lab InternacionalB de CV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Genomma Lab InternacionalB de CV Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Genomma Lab InternacionalB de CV Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

Genomma Lab InternacionalB de CV Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomma Lab InternacionalB de CV (Genomma Lab InternacionalB de CV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (OTCPK:GNMLF) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

LABB:Mexico GEKA:Germany

Address

Avenida Antonio Dovalí Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210

Website

https://www.genommalab.com

Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.